FDx Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $744K | Sell |
9,509
-11
| -0.1% | -$887 | 0.22% | 72 |
|
|
2026
Q1 | $825K | Buy |
+9,520
| New | +$912K | 0.26% | 69 |
|
|
2025
Q4 | – | Sell |
-3,155
| Closed | -$286K | – | 137 |
|
|
2025
Q3 | $286K | Sell |
3,155
-141
| -4% | -$13K | 0.09% | 135 |
|
|
2025
Q2 | $287K | Buy |
3,296
+27
| +0.8% | +$2.29K | 0.09% | 136 |
|
|
2025
Q1 | $294K | Buy |
+3,269
| New | +$293K | 0.1% | 130 |
|
|
2024
Q4 | – | Sell |
-2,588
| Closed | -$233K | – | 196 |
|
|
2024
Q3 | $233K | Sell |
2,588
-54
| -2% | -$4.54K | 0.06% | 180 |
|
|
2024
Q2 | $208K | Sell |
2,642
-812
| -24% | -$66.6K | 0.06% | 194 |
|
|
2024
Q1 | $301K | Sell |
3,454
-23,156
| -87% | -$1.98M | 0.05% | 288 |
|
|
2023
Q4 | $2.19M | Sell |
26,610
-1,670
| -6% | -$127K | 0.17% | 138 |
|
|
2023
Q3 | $2.22M | Sell |
28,280
-18,889
| -40% | -$1.58M | 0.18% | 123 |
|
|
2023
Q2 | $4.16M | Sell |
47,169
-52,132
| -52% | -$4.49M | 0.23% | 116 |
|
|
2023
Q1 | $7.72M | Hold |
99,301
| – | – | 0.34% | 70 |
|
|
2022
Q4 | $7.72M | Sell |
99,301
-2,458
| -2% | -$199K | 0.34% | 70 |
|
|
2022
Q3 | $8.22M | Sell |
101,759
-4,584
| -4% | -$412K | 0.37% | 63 |
|
|
2022
Q2 | $9.54M | Sell |
106,343
-3,949
| -4% | -$400K | 0.36% | 62 |
|
|
2022
Q1 | $12.2M | Sell |
110,292
-27,503
| -20% | -$2.91M | 0.41% | 49 |
|
|
2021
Q4 | $14.3M | Buy |
137,795
+25,060
| +22% | +$2.9M | 0.39% | 56 |
|
|
2021
Q3 | $14.1M | Buy |
112,735
+13,225
| +13% | +$1.71M | 0.45% | 46 |
|
|
2021
Q2 | $12.4M | Buy |
99,510
+5,422
| +6% | +$681K | 0.41% | 48 |
|
|
2021
Q1 | $11.1M | Buy |
94,088
+13,468
| +17% | +$1.58M | 0.42% | 49 |
|
|
2020
Q4 | $9.44M | Buy |
80,620
+3,544
| +5% | +$390K | 0.39% | 58 |
|
|
2020
Q3 | $8.01M | Buy |
77,076
+22,755
| +42% | +$2.29M | 0.38% | 63 |
|
|
2020
Q2 | $4.98M | Buy |
54,321
+2,287
| +4% | +$219K | 0.26% | 86 |
|
|
2020
Q1 | $4.69M | Buy |
52,034
+3,894
| +8% | +$414K | 0.31% | 81 |
|
|
2019
Q4 | $5.46M | Buy |
48,140
+10,995
| +30% | +$1.21M | 0.3% | 81 |
|
|
2019
Q3 | $4.04M | Buy |
37,145
+1,789
| +5% | +$187K | 0.28% | 78 |
|
|
2019
Q2 | $3.44M | Sell |
35,356
-843
| -2% | -$77K | 0.13% | 134 |
|
|
2019
Q1 | $3.3M | Sell |
36,199
-7,784
| -18% | -$697K | 0.13% | 125 |
|
|
2018
Q4 | $4M | Sell |
43,983
-12,699
| -22% | -$1.19M | 0.33% | 52 |
|
|
2018
Q3 | $5.58M | Buy |
56,682
+11,774
| +26% | +$1.09M | 0.21% | 81 |
|
|
2018
Q2 | $3.85M | Buy |
44,908
+40
| +0.1% | +$3.34K | 0.14% | 113 |
|
|
2018
Q1 | $3.6M | Buy |
44,868
+4,319
| +11% | +$356K | 0.11% | 154 |
|
|
2017
Q4 | $3.27M | Buy |
40,549
+3,990
| +11% | +$320K | 0.09% | 195 |
|
|
2017
Q3 | $2.84M | Buy |
36,559
+2,803
| +8% | +$233K | 0.08% | 220 |
|
|
2017
Q2 | $3M | Buy |
33,756
+8,746
| +35% | +$737K | 0.09% | 188 |
|
|
2017
Q1 | $2.02M | Buy |
25,010
+4,927
| +25% | +$385K | 0.06% | 279 |
|
|
2016
Q4 | $1.43M | Sell |
20,083
-4,658
| -19% | -$366K | 0.04% | 394 |
|
|
2016
Q3 | $2.14M | Sell |
24,741
-1,894
| -7% | -$165K | 0.09% | 193 |
|
|
2016
Q2 | $2.31M | Buy |
26,635
+1,242
| +5% | +$100K | 0.1% | 178 |
|
|
2016
Q1 | $1.9M | Sell |
25,393
-2,051
| -7% | -$154K | 0.09% | 205 |
|
|
2015
Q4 | $2.11M | Buy |
27,444
+5,814
| +27% | +$438K | 0.1% | 176 |
|
|
2015
Q3 | $1.45M | Sell |
21,630
-2,398
| -10% | -$177K | 0.12% | 167 |
|
|
2015
Q2 | $1.78M | Sell |
24,028
-3,672
| -13% | -$281K | 0.09% | 204 |
|
|
2015
Q1 | $2.16M | Buy |
27,700
+15,206
| +122% | +$1.15M | 0.05% | 312 |
|
|
2014
Q4 | $902K | Buy |
12,494
+327
| +3% | +$22.7K | 0.05% | 340 |
|
|
2014
Q3 | $754K | Buy |
12,167
+835
| +7% | +$53.1K | 0.05% | 419 |
|
|
2014
Q2 | $723K | Buy |
11,332
+4,869
| +75% | +$296K | 0.05% | 438 |
|
|
2014
Q1 | $398K | Buy |
+6,463
| New | +$376K | 0.03% | 512 |
|
Other funds holding MDT
FDx Advisors's MDT Position: Q2 2026 in Review
FDx Advisors reduced its Medtronic (MDT) stake by 0.12% in Q2 2026, selling an estimated $887 and leaving 9,509 shares worth $744K. The position accounts for 0.22% of the portfolio, ranked #72.
FDx Advisors first reported a position in MDT in Q1 2014 and has held it in 48 quarters since. The position peaked at $14.3M in Q4 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- FDx Advisors held 9,509 shares of Medtronic worth $744K as of Q2 2026.
- FDx Advisors sold 11 Medtronic shares in Q2 2026, an estimated $887.
- Medtronic made up 0.22% of FDx Advisors's portfolio in Q2 2026, its #72 holding.
- FDx Advisors first reported a position in Medtronic in Q1 2014 and has held it in 48 quarters since.
- FDx Advisors's Medtronic position peaked at $14.3M in Q4 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on FDx Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.